Related Funds
Fund Name | Location |
AE Jarrah Capital Group | - |
Commenda Capital | Atlanta, Georgia, United States |
Grindrod | Durban, KwaZulu-Natal, South Africa |
Grupo Prisma | Chile, Santiago Metropolitan Region, Vitacura |
Macif Innovation | - |
Race Capital | California, Hayward, United States |
Sibessor 2 | - |
STV Group | Douglassville, Pennsylvania, United States |
Yingke Beite Investment Management Enterprise | China, Guangdong, Shenzhen |
Yorkshire Cancer Research | Harrogate, North Yorkshire, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Jade Biosciences | $80M | 01 Aug 2024 | Waltham, Massachusetts, United States | ||
Apogee Therapeutics | $149M | 07 Dec 2022 | San Francisco, California, United States | ||
Dianthus Therapeutics | $100M | 19 Apr 2022 | Waltham, Massachusetts, United States | ||
Apogee Therapeutics | $20M | 01 Jan 2022 | San Francisco, California, United States | ||
Nuvalent | $135M | 11 May 2021 | Cambridge, Massachusetts, United States | ||
Zenas BioPharma | 23 Mar 2021 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Jade Biosciences | $80M | 01 Aug 2024 | Waltham, Massachusetts, United States | ||
Apogee Therapeutics | $149M | 07 Dec 2022 | San Francisco, California, United States | ||
Dianthus Therapeutics | $100M | 19 Apr 2022 | Waltham, Massachusetts, United States | ||
Apogee Therapeutics | $20M | 01 Jan 2022 | San Francisco, California, United States | ||
Nuvalent | $135M | 11 May 2021 | Cambridge, Massachusetts, United States | ||
Zenas BioPharma | 23 Mar 2021 | - |